latest news releases from the newsroom
Blyth, Inc. Reports 4th Quarter Sales and Earnings
GREENWICH, Conn., April 3, 2009 (GLOBE NEWSWIRE) -- Blyth, Inc. (NYSE:BTH), a leading multi-channel designer and marketer of home fragrance products, home decor products and household convenience items, today reported that Net Sales for the fourth quarter ended January 31, 2009 decreased approximately 16% to $313.4 million compared to $373.8 million for the prior year period. Foreign exchange had a 5 percentage point unfavorable impact on fourth quarter Net Sales. International sales represented 47% of total sales in the fourth quarter this year versus 42% last year.
Stoltmann Law Offices P.C.
Regions Financial Corp.'s Morgan Keegan Hit With Largest Bond Fund Arbitration Award To Date -- RF
SAN FRANCISCO, April 3, 2009 (GLOBE NEWSWIRE) -- A San Francisco, California FINRA arbitration panel this week awarded $267,711, plus interest, to two California residents for losses suffered in Morgan Keegan bond funds managed by James Kelsoe. "This is the largest arbitration award to date against Regions Financial Corp.'s (NYSE:RF) Morgan Keegan division for its derivative laced bond funds that were concentrated in highly speculative CMOs and CDOs," said attorney Andrew Stoltmann of Stoltmann Law Offices in Chicago, Illinois who was co-counsel for the Claimants along with Chicago attorney Thomas Burke.
IRIS International, Inc.
IRIS International Celebrates 30 Years of Excellence as Leading In-Vitro Diagnostics Company
CHATSWORTH, Calif., April 3, 2009 (GLOBE NEWSWIRE) -- IRIS International, Inc. (Nasdaq:IRIS), this week proudly celebrates 30 years of excellence as a leading in vitro diagnostics company, having evolved from its founding in 1979 as a fledgling research and development stage company with no revenue, to a company today approaching $100 million in sales and more than 300 employees serving the needs of urinalysis across the globe, delivering iQ brand recognized system automation and improving efficiency and quality at laboratories in more than 60 countries, Cesar Garcia, Chairman, President and Chief Executive Officer, announced today.
Medicis Pharmaceutical Corporation
Medicis Announces Notice of Allowance for SOLODYN(R) 90mg
SCOTTSDALE, Ariz., April 3, 2009 (GLOBE NEWSWIRE) -- Medicis (NYSE:MRX) today announced that the United States Patent and Trademark Office (USPTO) has issued a Notice of Allowance for Medicis' United States patent application directed to the use of SOLODYN(R) in 90mg tablet form. For the week ending March 20, 2009, the 90mg strength represented over 60% of total SOLODYN(R) prescriptions.(1)
Northrop Grumman Corp.
Northrop Grumman to Open New Office and Lab Facility in Suffolk
SUFFOLK, Va., April 3, 2009 (GLOBE NEWSWIRE) -- Northrop Grumman Corporation (NYSE:NOC) recently moved into its new three-story, 30,000 square-foot building at 8030 Harbour View Drive, where the company will continue to support joint military training.